LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $95,040.00 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Ujjwal Ramtekkar sold 16,000 shares of the stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the transaction, the insider now directly owns 113,435 shares of the company’s stock, valued at $673,803.90. This trade represents a 12.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

LifeStance Health Group Price Performance

LFST opened at $5.60 on Thursday. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company’s 50 day simple moving average is $6.19 and its 200-day simple moving average is $7.05. The stock has a market capitalization of $2.18 billion, a P/E ratio of -21.54 and a beta of 1.22.

Institutional Trading of LifeStance Health Group

Hedge funds have recently modified their holdings of the stock. Handelsbanken Fonder AB bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $128,000. Janus Henderson Group PLC grew its stake in shares of LifeStance Health Group by 51.4% during the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company’s stock valued at $439,000 after purchasing an additional 20,200 shares during the last quarter. Blue Trust Inc. grew its stake in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after purchasing an additional 2,122 shares during the last quarter. Northern Trust Corp boosted its stake in LifeStance Health Group by 11.7% in the fourth quarter. Northern Trust Corp now owns 1,591,776 shares of the company’s stock valued at $11,731,000 after acquiring an additional 166,731 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock valued at $25,546,000 after acquiring an additional 13,293 shares during the last quarter. 85.50% of the stock is owned by institutional investors.

Analysts Set New Price Targets

LFST has been the subject of several recent analyst reports. KeyCorp initiated coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective for the company. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. Finally, UBS Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price objective for the company in a report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, LifeStance Health Group presently has an average rating of “Moderate Buy” and a consensus price target of $8.50.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.